Search details
1.
Neo-adjuvant and/or Adjuvant Subcutaneous Trastuzumab (Herceptin®) in Patients With Early HER2-positive Breast Cancer: Real World Data from a German Observational Study - (NIS HerSCin).
Anticancer Res
; 41(1): 485-496, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-33419847
Results
1 -
1
de 1
1
Next >
>>